Changeflow GovPing Healthcare & Life Sciences Observational HPV Testing Study Before Subtotal...
Routine Notice Added Final

Observational HPV Testing Study Before Subtotal Hysterectomy

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

Clinical trial NCT07545525 is an observational study registered on April 22, 2026, evaluating high-risk HPV testing in patients indicated for subtotal hysterectomy. Patients testing HPV-positive will proceed to expert colposcopy and conisation if clinically indicated at the time of hysterectomy. The study screens for cervical cancer and human papilloma virus as co-occurring conditions.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.

What changed

This entry registers a new observational clinical trial on ClinicalTrials.gov. The study will test patients indicated for subtotal hysterectomy for high-risk HPV; those testing positive will undergo expert colposcopy and conisation if not otherwise contraindicated at the time of surgery. No new regulatory obligations are imposed by this registration.

Healthcare providers and clinical investigators involved in cervical cancer screening or hysterectomy care are not subject to new compliance requirements from this registry entry. The study may be of interest to researchers in gynecologic oncology and cervical dysplasia management seeking to understand HPV testing integration into pre-surgical pathways.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy

Observational NCT07545525 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

Patients indicated for subtotal hysterectomy will be tested for High risk HPV and if the result is positive will undergo expert colposcopy and conisation if not indicated otherwise at the time of subtotal hysterectomy

Conditions: Cervical Cancer Screening, Human Papilloma Virus (HPV)

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration HPV screening Gynecologic surgery
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!